South African scientists access European research via EMBC agreement
South African scientists will gain access to the latest thinking in molecular biology research through an agreement announced by the European Molecular Biology Organization (EMBO). The Government of the Republic of South Africa signed a cooperation agreement with the European Molecular Biology Conference (EMBC), the intergovernmental funding body for EMBO, allowing scientists from South Africa to participate in EMBO programmes and activities. The agreement also provides for some EMBO activities to occur in South Africa.
EMBO recognises and fosters talented scientists, empowering them to advance the field of molecular biology. The cooperation agreement facilitates access for South African scientists to core EMBO programmes, such as EMBO Fellowships, EMBO Courses & Workshops and EMBO Young Investigator Programme.
"Scientists the world over benefit from access to funding, the latest research information and networking with their colleagues," said Hermann Bujard, EMBO Executive Director. "EMBO is delighted to welcome South African scientists to join our networks that foster collaboration and information exchange."
EMBO annually will sponsor one practical course or workshop and one plenary lecture held in South Africa, thus encouraging local participation and awareness. Up to three South African scientists will have the opportunity to network with young European group leaders at EMBO Young Investigator meetings. EMBO Life Sciences Mobility Portal will post targeted information for reciprocal career development and funding opportunities between South Africa and Europe.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Bayer achieves strong gains in sales and earnings - Sales advance by 5.3 percent to EUR 8,316 million
Huntingdon Life Sciences Acquires Harlan Laboratories

COVID-19: A potential treatment for loss of smell
Leprosy strain genotyped from medieval pilgrim at UK burial site - Medieval leprosy victim in UK cemetery was likely a religious pilgrim, possibly from overseas
Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe
Europe challenges USA in stem cell research

Overcome food allergies and sensitivities - Ukko secures USD 40 million in Series B funding led by Leaps by Bayer

Supermicroscope for Protein Crystals - Combination of techniques locates microcrystals for structural analysis

This one-atom chemical reaction could transform drug discovery - This nearly unprecedented work could simplify and lower the cost of pharmaceutical synthesis

Tailor-made Metal Complexes for Medical Diagnostics and Therapy - Chemists study manganese, lutetium, and actinium compounds for potential applications in medicine
